Gold complexes with 2-selenoxo-1,3-dithiole-4,5-dithiolato

DOI: 10.1016/S0277-5387(97)00302-1

Source and publish data:

Polyhedron p. 295 - 298 (1998)

Update date:2022-08-03

Topics:

Authors:

Cerrada, Elena

Laguna, Mariano

Sorolla, Pedro A.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/S0277-5387(97)00302-1

The reaction of Na₂dmise (dmise = 2-selenoxo-1,3-dithiole-4,5-dithiolate) with [AuClL] in 1:2 molar ratio affords [Au₂(dmise)L₂] (L = PR₃ or CH₂PPh₃) but in 1:1 ratio in the presence of (NB

Full text of DOI:10.1016/S0277-5387(97)00302-1

Products guided by the article

Product name:Au₂(C₃S₄Se)(P(C₆H₅)3)2

Cas No:201612-30-8

R&D Labs maybe for 201612-30-8

Oceachem Group Limited

website:http://www.oceanchem-group.com

Contact:86-536-8596048

Address:9th floor,Building B future Plaza, No.88.Fenghuang Street,Weifang,Shandong,China
JiangXi Hong Run Chemical Co., Ltd

Contact:+86-0791-88521351

Address:XingHuo industrial zone in YongXiu county
Hubei Vanz Pharm Co.,Ltd

website:http://www.vanzpharm.com/en/index.html

Contact:86-27-84492310

Address:FANHU INDUSTRY PARK
Chengdu Biopurify Phytochemicals Ltd.

website:http://www.phytopurify.com

Contact:+86-28-82633397

Address:2F,No.11 Building,No.388 Rongtaidadao CNSTP,Wenjiang Zone,Chengdu,Sichuan, China
Rugao Jinling Chemical Co., Ltd.(expird)

Contact:0086-513-68005586

Address:Lianluo new village huangshi town Rugao city Jiangsu Province.

Relevant to this article

A calixarene with four peptide loops: An antibody mimic for recognition of protein surfaces

Doi:10.1002/anie.199726801
(1997)
Doi:10.1021/ja01137a001
(1952)
The total synthesis of lipid I

Doi:10.1021/ja016082o
(2001)
An enantioselective synthesis of cis perhydroisoquinoline LY235959

Doi:10.1021/jo9717649
(1998)
Stereocontrol in nickel mediated syntheses of cyclobutabenzenes. The selective preparation of cis and trans derivatives of 7,8-dibromocyclobutabenzene

Doi:10.1016/S0040-4020(97)10219-8
(1998)
(Phenylpiperidinyl)cyclohexylsulfonamides: Development of α_1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS)

Doi:10.1016/j.bmcl.2007.04.098
(2007)

Article Doi